YU, YING,DENKER, ANDREW EVAN,SADEKOVA, SVETLANA,PHAN, UYEN TRUONG,KASTELEIN, ROBERT A.,KAUFMAN, DAVID ROSS,COFFMAN, ROBERT L.,GUIDUCCI, CRISTIANA,JANSSEN, ROBERT S.
申请号：
CA2986126
公开号：
CA2986126A1
申请日:
2016.05.26
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Toll-like receptor 9 (TLR9) agonist that is a CpG-C type oligonucleotide, and the use of the combination therapies for the treatment of cancer.
